WhatsApp
backNews Article

Vinati Organics Posts 21% Revenue Growth to INR 707 Crores in Q2 FY2027 Amid Rising Costs; Announces INR 500 Crore Capex for Specialty Chemicals

Despite EBITDA and PAT declines due to market and logistics challenges, the company expects volume recovery in H2 and plans significant investment in new chemical product development

Vinati Organics Ltd announced its Q2 FY2027 financial results with a 21% year-on-year revenue increase to INR 707 crores, despite EBITDA and PAT declines. The company outlined challenges from rising costs and geopolitical tensions, expects H2 volume recovery, and revealed a INR 500 crore capex to develop new specialty chemicals focused on fragrances, personal care, and more, funded through internal accruals over two years.

09 Nov 2026|VINATIORGA-1.08%
Vinati Organics LimitedVINATIORGAEarnings Call Transcript

Vinati Organics Limited

Earnings Call Transcript

Vinati Organics Limited reported a 21% year-on-year increase in net income to INR 707 crores for Q2 FY2027 but experienced declines in EBITDA and profit after tax due to increased costs amid geopolitical tensions. The company announced a INR 500 crore capex plan to expand its specialty chemicals portfolio, expected to commercialize in two years and funded through internal accruals.

The company’s standalone net income rose from INR 562 crores in Q2 FY2026 to INR 707 crores in Q2 FY2027, while EBITDA fell 27% to INR 142 crores and profit after tax dropped 33% to INR 87 crores.

Challenges included increased raw material, energy, and logistics costs due to the ongoing Middle East conflict, with only partial pass-through of these costs to customers affecting profitability.

On a consolidated basis, net income increased by 23% to INR 693 crores year-on-year, with EBITDA declining 24% and PAT falling 15% compared to the prior year quarter.

The ATBS segment faced demand shortfalls due to customer destocking but is expected to recover in H2 FY2027, while other segments like Butyl Phenol, Antioxidants, IB, and IBB showed stable or strong performances.

Vinati Organics forecasts a 20%-25% revenue growth for FY2027 driven by volume and pricing improvements, with process re-engineering underway for some products to enhance contributions from its consolidated entity VOPL.

Highlights

  • 21% year-on-year net income increase to INR 707 crores in Q2 FY2027 on standalone basis.
  • 27% reduction in EBITDA to INR 142 crores and 33% decrease in profit after tax to INR 87 crores due to cost pressures.
  • Geopolitical tensions have raised raw material, energy, and logistics costs, partially impacting margins.
  • Demand for ATBS subdued due to customer destocking, with H2 FY2027 expected volume recovery.
  • Announced INR 500 crore capex for specialty chemicals development, funded internally and targeting commercialization in two years.
  • Additional INR 500 crore capex planned pending land acquisition, also funded through internal accruals.

Key Data Snapshot

Standalone Net Income Q2 FY2027INR 707 crores
Standalone EBITDA Q2 FY2027INR 142 crores
Standalone Profit After Tax Q2 FY2027INR 87 crores
Consolidated Net Income Q2 FY2027INR 693 crores
Consolidated EBITDA Q2 FY2027INR 138 crores
Consolidated Profit After Tax Q2 FY2027INR 187 crores
Declared Capital ExpenditureINR 500 crores
Additional Planned CapexINR 500 crores
Expected Commercialization Timeline for CapexTwo years
Top Product Segment Contribution - ATBS27%-28%
Top Product Segment Contribution - Butyl Phenols16%-20%
Top Product Segment Contribution - Antioxidants (AO)15%-17%
Top Product Segment Contribution - IBB12%-15%

What happened

  • Vinati Organics Limited reported a 21% year-on-year increase in net income to INR 707 crores for Q2 FY2027 on a standalone basis.
  • EBITDA declined by 27% to INR 142 crores, and profit after tax dropped by 33% to INR 87 crores due to higher raw material, energy, and logistics costs.
  • On a consolidated basis, net income increased 23% to INR 693 crores while EBITDA and PAT declined 24% and 15%, respectively.
  • The company attributes profitability pressures to increased costs, partly due to the ongoing geopolitical conflict in the Middle East.
  • A planned INR 500 crore capital expenditure aims to develop and commercialize new specialty chemicals over two years, funded entirely through internal accruals.

Operational performance

  • ATBS segment demand was weaker than expected due to customer destocking, impacting half-year targets but volume recovery is anticipated in the second half.
  • Butyl Phenol segment maintained stable performance with expectations to improve in H2 FY2027.
  • Antioxidant and IBB product segments exhibited strong performances during H1 FY2027 and are expected to sustain momentum.
  • Some products under the VOPL entity require process re-engineering, which is underway to enhance future contributions.
  • Logistics costs started to decline in Q3 FY2027, potentially improving profitability in the latter half of the fiscal year.

Funding and capital details

  • Announced INR 500 crore capex to develop specialty chemicals with applications in fragrances, personal care, water treatment, and oil fields.
  • The capex will be entirely funded through internal resources and is expected to be commercialized within two years.
  • An additional INR 500 crore capex is under planning, pending land acquisition decisions, also to be funded through internal accruals.

More News on Earnings Call Transcript

View all

Latest corporate announcements and market updates in Earnings Call Transcript.

View all news
Vinati Organics Posts 21% Revenue Growth to INR 707 | Stockk News